Speaker

Virginia Amann

CEO/FOUNDER, ENTENTE HEALTH & SCIENCE COMMUNICATIONS
"Virginia Amann is a growth strategist championing innovation and health companies through Social Impact Communications, Corporate Affairs, Corporate Reputation, and Brand Strategy.
She founded ENTENTE Behavior Science group in 2022 to address human behavioral issues that impact clinical trials diversity.
She has 25 years in strategic communications, specializing in life sciences, pharmaceutical companies and medical device and diagnostics companies – from trust in science to partnering and fundraising.
Virginia led a full portfolio of life sciences companies across therapeutic areas and modalities as part of the top leadership of a life sciences boutique agency through its acquisition to top three multinational public relations firm Porter Novelli. She headed life sciences within Porter Novelli and served as client relationship manager for the Johnson & Johnson global portfolio. She then served as a fractional advisor to Johnson & Johnson’s topmost leadership to position the company’s public health, innovation and R&D for nearly 10 years. She most recently led development and management of the Science Over Stigma mental health coalition with J&J’s Head of Science for Minds, Husseini Manji. She is currently active in the mental health community as an advocate and champion for non-profit organizations. At the forefront of trends in digital and traditional communications, Virginia taps her extensive network of high-level media, thought leaders and financial and industry relationships to create opportunity, visibility and reputation for companies and executives."
Speaking In
2:15 PM - 3:15 PM
Monday, June 5
In April 2022, FDA issued draft guidance on developing a Race and Ethnicity Diversity Plan to…